What Analysts Are Saying About DermTech Stock
What Analysts Are Saying About DermTech Stock
分析師對DermTech股票的看法
DermTech (NASDAQ:DMTK) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
DermTech（納斯達克股票代碼：DMTK）在上個季度接受了4位分析師的分析，揭示了從看漲到看跌的一系列觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $1.41, a high estimate of $2.00, and a low estimate of $0.63. A 56.62% drop is evident in the current average compared to the previous average price target of $3.25.
分析師分析的12個月目標股價提供了見解，平均目標價爲1.41美元，最高估計爲2.00美元，低估值爲0.63美元。與之前的平均目標股價3.25美元相比，當前的平均價格下降了56.62％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The...
通...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。